ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$37.850-0.750 (-1.943%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$38.600

Máximo

$39.310

Mínimo

$37.770

Volume

1.40M

Fundamentos da empresa

Capitalização de mercado

5.2B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

2.39M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $9.57Atual $37.850Máximo $43.69

Notícias relacionadas

BusinessWire

Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming events: American Heart Association (AHA) Scientific Sessions 2025 – November 7-10,

Ver mais
Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences
BusinessWire

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on October 24, 2025, the Company's Board of Directors approved "inducement" grants to 84

Ver mais
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BusinessWire

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that a global licensing and collaboration agreement with Novartis, previously announced on September 2, 2025, has now closed. Closing of the transaction was

Ver mais
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.